Clinical Trials in Boston

Showing 2741-2760 of 17,836 trials

Prostate Active Surveillance Study

NCT00756665

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.

Prostatic Neoplasms

University of Washington3,000 participantsStarted Jul 2008

San Francisco, California, United States • San Francisco, California, United States • Stanford, California, United States +8 more locations

COMPLETEDPhase 3< 1 mile

The Safety and Efficacy of SYD-101 in Children With Myopia

NCT03918915

Myopia, or nearsightedness, is the most common eye disorder, often affecting more than 40% of adults in Europe, Asia and the USA. Severe myopia is associated with an increased risk of developing other eye conditions such as glucoma, cataracts and retinal detachment, which may lead to blindness. Early treatment of myopia in children could help slow the condition and minimize the risk of complications later in life. This study investigates the use of SYD-101, an eye solution, in slowing-down the progression of myopia in children.

NearsightednessNear SightednessNear-sightedness

Sydnexis, Inc.852 participantsStarted Apr 2019

Irwindale, California, United States • Pasadena, California, United States • San Diego, California, United States +44 more locations

Prostate Active Surveillance Study

The Safety and Efficacy of SYD-101 in Children With Myopia

Find Trials by Condition in Boston

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Assessment of CCM in HF With Higher Ejection Fraction

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Harm Reduction for Smokers With Mental Illness

Removing Transfusion Dependence as a Barrier to Hospice Enrollment

Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

A Study of DM005 in Patients With Advanced Solid Tumors

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)